C Richard Conti. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Aldosterone/physiologyAngiotensin-Converting Enzyme Inhibitors/pharmacologyAngiotensin-Converting Enzyme Inhibitors/therapeutic useCardiovascular Physiological Phenomena/drug effectsCardiovascular System/drug effectsDrug Therapy, CombinationEplerenoneHumansHypertension/drug therapyHypertension/etiologyPeptidyl-Dipeptidase A/drug effectsPeptidyl-Dipeptidase A/physiologyRenin-Angiotensin System/drug effectsRenin-Angiotensin System/physiologySpironolactone/analogs & derivativesSpironolactone/pharmacologySpironolactone/therapeutic useTreatment Outcome
Substances： See more » Angiotensin-Converting Enzyme InhibitorsSpironolactoneAldosteroneEplerenonePeptidyl-Dipeptidase A
Year: 2003 PMID： 12769246 PMCID： PMC6654361 DOI： 10.1002/clc.4960260502
Source DB: PubMed Journal: Clin Cardiol ISSN： 0160-9289 Impact factor: 2.882